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Background: Bacteriocins are protein antimicrobial agents that are produced by all prokaryotic lineages. Escherichia
coli strains frequently produce the bacteriocins known as colicins. One of the most prevalent colicins, colicin M, can
kill susceptible cells by hydrolyzing the peptidoglycan lipid II intermediate, which arrests peptidoglycan
polymerization steps and provokes cell lysis. Due to the alarming rise in antibiotic resistance and the lack of novel
antimicrobial agents, colicin M has recently received renewed attention as a promising antimicrobial candidate.
Here the effects of subinhibitory concentrations of colicin M on whole genome transcription in E. coli were
investigated, to gain insight into its ecological role and for purposes related to antimicrobial therapy.
Results: Transcriptome analysis revealed that exposure to subinhibitory concentrations of colicin M altered
expression of genes involved in envelope, osmotic and other stresses, including genes of the CreBC two-
component system, exopolysaccharide production and cell motility. Nonetheless, there was no induction of biofilm
formation or genes involved in mutagenesis.
Conclusion: At subinhibitory concentrations colicin M induces an adaptive response primarily to protect the
bacterial cells against envelope stress provoked by peptidoglycan damage. Among the first induced were genes of
the CreBC two-component system known to promote increased resistance against colicins M and E2, providing
novel insight into the ecology of colicin M production in natural environments. While an adaptive response was
induced nevertheless, colicin M application did not increase biofilm formation, nor induce SOS genes, adverse
effects that can be provoked by a number of traditional antibiotics, providing support for colicin M as a promising
antimicrobial agent.
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In their natural environments, bacteria are frequently
exposed to various stresses, including antimicrobials. It
has been generally assumed that the role of antibiotics in
nonclinical environments is the inhibition of competitors.
Nevertheless, antibiotic concentrations in natural habitats
can be variable, with high concentrations only in the
vicinity of the producer. Recent studies have shown that
antibiotics can act in a concentration-dependent manner
that exhibits dual ecological roles: (i) at high con-
centrations they can destroy microorganisms; while (ii) at
low concentrations they can modulate bacterial gene ex-
pression to promote ecological adaptation [1,2].* Correspondence: darja.zgur.bertok@bf.uni-lj.si
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distribution, and reproduction in any mediumBacteriocins are ribosomally synthesized antimicrobial
agents that are produced by all prokaryotic lineages and
they are generally active against closely related species.
Among the best characterized bacteriocins are those
produced by Escherichia coli, which are known as
colicins. The majority of colicins act by membrane
permeabilization, followed by nuclease activity, while
one colicin, colicin M, inhibits peptidoglycan synthesis.
Uptake of colicin M proceeds by binding to the FhuA
outer membrane receptor followed by energy-dependent
translocation into the periplasm through the TonB system
(TonB, ExbB and ExbD) and the proton motive force of
the inner membrane [3]. Colicin M is a phosphotase that
cleaves the undecaprenyl-phosphate-linked peptidoglycan
precursor, lipid II producing free undecaprenol and
1-pyrophospho-Mur-GlCNAc-pentapeptide. In the peri-
plasm, hydrolysis of peptidoglycan lipid precursors resultsioMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Growth of MG1655 without and with colicin M. The
arrow denotes the time of addition of colicin M at subinhibitory
concentrations (30 ng/ml). The experiment was performed three
times, and the means ± standard errors of the means (error bars)
are shown.
Figure 2 Venn diagram of gene expression in 30 min and
60 min treated E. coli MG1655. Time course analysis of
differentially expressed genes, reveals number of genes induced
following 30 min and 60 min exposure to subinhibitory
concentrations of colicin M.
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that encode colicin M and B are tightly linked on large
conjugative plasmids [5,6], and these are among the most
abundant colicins produced by E. coli strains [7].
A number of studies have been aimed at defining the
function of colicins in microbial communities. They might
serve to enable invasion or defense of an ecological niche
[8]. They have been shown to mediate population and
community level interactions, promoting microbial diver-
sity within E. coli populations in the mammalian colon
[9]. To obtain more insight into the ecological roles of one
of the most prevalent colicins, the effects of subinhibitory
concentrations of colicin M on genome wide transcription
in E. coli was studied.
Antibiotic resistance currently represents one of the
greatest worldwide threats to human health therefore,
novel antibiotics are urgently needed. Antibiotic resist-
ance among the Enterobacteriaceae represents a particu-
lar threat [10,11]. As colicin M promotes the irreversible
hydrolysis of lipid II, a peptidoglycan lipid intermediate
that is common to all bacteria, it is also a promising can-
didate for development of a novel antimicrobial agent
[12]. Analysis of the gene expression profile was thus also
undertaken, to acquire insight into adaptive responses to
colicin M that might be detrimental during antimicrobial
therapy.
Results and discussion
Transcriptome analysis of E. coli MG1655 exposed to
subinhibitory concentrations of colicin M
The effects of colicin M on whole genome transcription
of E. coli MG1655, a laboratory strain with minimal gen-
etic manipulation that approximates the wild type [13],
was investigated by microarray analysis. To choose the
appropriate conditions for determing the colicin M
induced transcriptome, mid-exponential phase cultures of
strain MG1665 were exposed to various concentrations of
colicin M and the growth response was monitored. On
the basis of these results a concentration of 30 ng/ml
was determined as subinhibitory and chosen for transcrip-
tome analysis. To focus on stress responses provoked
by colicin M, samples were collected as growth slowed,
30min following exposure to colicin M and upon
regrowth, 60min following exposure to colicin M, Figure 1
(see also Additional file 1: Figure S1 and Additional file 2:
Figure S2).
The 30 min exposure up-regulated the expression of 49
genes, with 2 genes down-regulated (log2 fold change >1
and < −1, P ≤0.05). On the other hand, the 60-min expos-
ure to colicin M significantly up-regulated the expression
of 210 genes, with expression of 51 genes down-regulated
(log2 fold change >1 and < −1, P ≤0.05). Time course ana-
lysis showed that 46 genes were differentially expressed
following 30 and 60 min colicin M treatment while 5 weredifferentially expressed only after 30 min treatment,
(Figure 2). Whereas 30 min exposure provoked diffe-
rential expression of a limited number of genes across
several gene groups, more genes were altered in their ex-
pression (extensive transcriptional changes were observed)
following 60min treatment. Among the first significantly
induced genes were those of two component sensory sys-
tems and several genes encoding membrane proteins.
Time course analysis of differential gene expression,
after 30 and 60min treatment, is presented in Additional
file 3: Table S1 (log2 fold change >1 and < −1, P ≤0.05).
Genes considered for interpretation are presented in
Table 1 and are described below.
Table 1 Genes with modulated expression after exposure to colicin M over time, 30 and 60 min
Category/Gene symbol Gene accession No. Gene description 30 min log2 ratio 60 min log2 ratio
Envelope stress regulators/systems
rcsA 946467 DNA-binding transcriptional activator, co-regulator
with RcsB
3.38 6.13
cpxP 2847688 inhibitor of the cpx response; periplasmic adaptor
protein
1.57 2.61
pspA 945887 regulatory protein for phage-shock-protein operon 1.35 1.18
pspB 945893 DNA-binding transcriptional regulator of psp operon 1.32 1.47
pspC 945499 DNA-binding transcriptional activator 1.14 1.52
pspD 945635 peripheral inner membrane phage-shock protein 0.83 1.78
pspG 948557 phage shock protein G 1.55 2.29
Colanic acid biosynthetic process
wza 946558 lipoprotein required for capsular polysaccharide
translocation through the outer membrane
3.59 7.12
wzb 946564 protein-tyrosine phosphatase 2.44 6.33
wzc 946567 protein-tyrosine kinase 1.52 6.72
wcaA 946570 predicted glycosyl transferase 0.93 5.7
wcaB 946573 predicted acyl transferase 0.69 5.73
wcaC 946579 predicted glycosyl transferase 0.56 5.47
wcaD 946550 predicted colanic acid polymerase 0.78 7.23
wcaE 946543 predicted glycosyl transferase 1.25 7.26
wcaF 946578 predicted acyl transferase 0.97 7.21
gmd 946562 GDP-D-mannose dehydratase, NAD(P)-binding 0.71 6.65




gmm 946559 GDP-mannose mannosyl hydrolase 0.3 6.15
wcaI 946588 predicted glycosyl transferase 0.3 5.92
cpsG 946574 phosphomannomutase 0.09 5.15
cpsB 946580 mannose-1-phosphate guanyltransferase 0.26 5.1
wcaJ 946583 predicted UDP-glucose lipid carrier transferase 0.11 4.82
wzxC 946581 predicted colanic acid exporter 0.1 4.45
wcaK 946569 Colanic acid biosynthesis protein −0.12 4.45
wcaL 946565 predicted glycosyl transferase −0.13 3.63
manA 944840 mannose-6-phosphate isomerase 0.19 1.05
ugd 946571 UDP-glucose 6-dehydrogenase 0.46 4.36
wcaM 946561 colanic acid biosynthesis protein −0.01 2.71
galU 945730 glucose-1-phosphate uridylyltransferase 0.44 1.4
Extracellular polysaccharide distinct from colanic acid
yjbE 948534 predicted protein 1.55 5.74
yjbF 948533 predicted lipoprotein 1.73 5.67
yjbG 948526 conserved protein 0.67 4.29
yjbH 948527 predicted porin 0.66 5.23
Peptidoglycan synthesis
anmK 946810 anhydro-N-acetylmuramic acid kinase 0.16 1.17
mrcB 944843 fused glycosyl transferase and transpeptidase 0.47 1.01
ycfS 945666 L,D-transpeptidase linking Lpp to murein 0.77 2
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Table 1 Genes with modulated expression after exposure to colicin M over time, 30 and 60 min (Continued)
Osmotic stress response
osmB 945866 lipoprotein 2.41 2.95
osmC 946043 osmotically inducible, stress-inducible membrane
protein
0.44 1.15
opgB 948888 phosphoglycerol transferases I and II 0.12 1.27
opgC 946944 membrane protein required for succinylation of
osmoregulated periplasmic glucans (OPGs)
0.31 1.85
ivy 946530 inhibitor of vertebrate C-lysozyme 1.55 1.26
mliC 946811 inhibitor of C-lysozyme, membrane-bound;
predicted lipoprotein
2.17 3.92
ybdG 946243 predicted mechanosensitive channel 0.69 1.26
dppB 948063 dipeptide/heme transporter −0.29 3.29
dppF 948056 dipeptide transporter −0.1 2.33
dppC 948064 dipeptide/heme transporter −0.09 2.33
dppD 948065 dipeptide/heme transporter −0.09 2.1
dppA 948062 dipeptide transporter 0.02 1.13
Other stress responses
ydeI 946068 conserved protein 1.99 3.96
treR 948760 DNA-binding transcriptional repressor 0.65 1.88
ibpA 948200 heat shock chaperone −0.01 1.78
ibpB 948192 heat shock chaperone 0.02 2.9
hslJ 946525 heat-inducible lipoprotein involved in novobiocin
resistance
2.33 3.32
yhbO 947666 predicted intracellular protease 2.29 2.67
iraM 945729 RpoS stabilizer during Mg starvation, anti-RssB factor 0.33 1.6
creD 948868 inner membrane protein 5.66 4.96
cbrB 948231 inner membrane protein, creBC regulon 5.2 4.29
cbrA 948197 predicted oxidoreductase with FAD/NAD(P)-binding
domain
4.3 3.35
cbrC 948230 conserved protein, UPF0167 family 3.77 2.8
spy 946253 envelope stress induced periplasmic protein 1.71 2.99
htpX 946076 predicted endopeptidase 0.27 1.01




ycfJ 945977 predicted protein 4.77 5.8
rprA 2847671 ncRNA 3.86 4.85
omrA 2847746 ncRNA 0.36 1.76
omrB 2847747 ncRNA 0.77 1.74
bdm 946041 biofilm-dependent modulation protein 4.49 4.21
ydeH 946075 diguanylate cyclase, required for pgaD induction 1.38 1.68
Cell motility
fliZ 946833 RpoS antagonist; putative regulator of FliA activity −0.41 −1.05
fliE 946446 flagellar basal-body component −0.66 −1.07
fliG 946451 flagellar motor switching and energizing component −0.28 −1.07
flgN 945634 export chaperone for FlgK and FlgL −0.29 −1.12
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Table 1 Genes with modulated expression after exposure to colicin M over time, 30 and 60 min (Continued)
flgA 946300 assembly protein for flagellar basal-body periplasmic
P ring
−0.09 −1.17
flgF 945639 flagellar component of cell-proximal portion of
basal-body rod
−0.29 −1.21
flgM 946684 anti-sigma factor for FliA (sigma 28) −0.27 −1.23
fliA 948824 RNA polymerase, sigma 28 (sigma F) factor −0.21 −1.45
flgD 945813 flagellar hook assembly protein −0.33 −1.61
flgE 945636 flagellar hook protein −0.05 −1.72
flgC 946687 flagellar component of cell-proximal portion of
basal-body rod
−0.04 −2.14
flgB 945678 flagellar component of cell-proximal portion of
basal-body rod
−0.19 −2.4
flhC 947280 DNA-binding transcriptional dual regulator with FlhD −0.76 −2.54
flhD 945442 DNA-binding transcriptional dual regulator with FlhC −0.76 −2.54
Amino acid transport/acid resistance
glnP 945621 glutamine transporter subunit −0.23 −1.17
gadB 946058 glutamate decarboxylase B, PLP-dependent 0.03 −1.18
glnQ 945435 glutamine transporter subunit −0.15 −1.25
glnG 948361 fused DNA-binding response regulator in two-
component regulatory system with GlnL: response
regulator/sigma54 interaction protein
−0.15 −1.32
gadA 948027 glutamate decarboxylase A, PLP-dependent −0.23 −1.64
gadE 948023 DNA-binding transcriptional activator 0.13 −1.38
slp 948022 outer membrane lipoprotein −0.18 −1.91
hdeB 948026 acid-resistance protein 0.13 −1.17
hdeD 948024 acid-resistance membrane protein −0.01 −1.04
Poorly characterized
ymgD 945732 predicted protein 3.45 3.65
ymgG 945728 conserved protein, UPF0757 family 3.87 3.55
yfdC 944801 predicted inner membrane protein 1.02 2.25
yjbJ 948553 conserved protein, UPF0337 family 0.97 1.19
yaaX 944747 predicted protein 1.59 4.12
yegS 946626 phosphatidylglycerol kinase, metal-dependent 0.81 1.65
yaiY 945223 inner membrane protein, DUF2755 family 3.94 5.22
(bold indicates genes with gene expression log2 ratio (fold change) ≥1 and ≤−1, denoting fold change ≥2 or ≤−2, and with p≤0.05, and italic indicates genes
with p≥0.05).
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The bacterial envelope protects the bacterial cell from ex-
ternal stress and performs essential functions such as,
transport of nutrients and waste, as well as respiration and
adhesion. In Gram-negative bacteria the outer membrane
acts as a permeability barrier, with porins for transport
and protection against phagocytosis [14] while processes
central for energy generation and nutrient transport occur
in the inner membrane [15]. In the periplasmic space
peptidoglycan ensures the structural integrity of the cell
by preventing osmolysis. To sense and rapidly respond
to environmental signals, bacteria primarily use two-
component signal transduction systems, composed ofan inner membrane histidine kinase and a cytoplasmic
response regulator [16].
Peptidoglycan is the major structural component of the
bacterial cell wall. It provides the bacterial cell structural
strength and protects the osmotically sensitive membrane
[17]. As expected, by targeting peptidoglycan synthesis,
colicin M induced an envelope stress response. In E. coli
envelope homeostasis is monitored by several stress
responses; namely, Rcs, Cpx, Psp, σE, Bae and vesicle re-
lease responses [18-20]. Our microarray analysis revealed
that the Rcs regulon has a major role in the response to
envelope stress induced by colicin M. RcsC and RcsD are
inner-membrane-bound proteins, with RcsC as the sensor
Kamenšek and Žgur-Bertok BMC Microbiology 2013, 13:42 Page 6 of 13
http://www.biomedcentral.com/1471-2180/13/42kinase that autophosphorylates upon sensing the appro-
priate signal, while RcsD transfers the phosphoryl group
to the transcriptional regulator RcsB. Certain promoters
require the RcsA protein to act as an auxiliary regulatory
protein, apparently exerting its effects by forming a
heterodimer with RcsB [21]. The Rcs system controls the
production of exopolysaccharides [22], biofilm formation
[23,24], cell motility, and chemotaxis [25]. We observed in-
duction of rcsA and a number of other Rcs-regulated genes:
the exopolysaccharide operons wca for colanic acid synthe-
sis, and yjbEFGH, as well as genes osmB, ymgG and ymgD,
ivy, yfbR, ugd, yfdC, yjbJ, galU, yaaX, yggG, yegS, spy, rprA,
bdm and yaiY (Table 1). Recently, perturbations to peptido-
glycan by several ß-lactam antibiotics were shown to elicit
shared as well as unique responses with all activating the
Rcs system [26] indicating that, the Rcs pathway elicits a
global response to peptidoglycan stress [27].
Colicin M treatment also induced the expression of
cpxP, which encodes the periplasmic inhibitor of the Cpx
envelope stress response. The Cpx system appears to
sense misfolded proteins that are synthesized for the
periplasm, and it is controlled by the sensor kinase CpxA,
the response regulator CpxR, and the periplasmic inhibi-
tor CpxP. CpxP has been assumed to fine tune Cpx activa-
tion during envelope stress, by preventing its incorrect
activation and enabling its rapid shut-down following en-
velope stress relief [28].
Treatment with colicin M also up-regulated a third
cell envelope stress system, the psp genes that encode
the membrane-bound phage shock proteins: PspA, PspB,
PspC, PspD and PspG. The psp regulon consists of the
psp operon with genes pspA, pspB, pspC, pspD and pspE,
as well as genes pspF and pspG. Proteins PspB, PspC and
PspD are located in the inner membrane, while PspA is
on the cytoplasmic side of the inner membrane. In the
absence of stress, PspA binds to protein PspF, thus
inhibiting transcription of the psp operon. The psp genes
are induced by filamentous phage infection and other
stresses that impair cell membrane function [29,30]. This
system is responsible for repair of inner membrane dam-
age and maintenance of the proton motive force across
the inner membrane [31,32]. Peptidoglycan damage
provoked by colicin M exposes the sensitive inner mem-
brane to osmotic damage requiring activation of mem-
brane repair mechanisms.
Colicin M induces expression of exopolysaccharide genes
Among the most strongly up-regulated genes, were those
of the wca operon, which encodes the production of the
exopolysaccharide, colanic acid [33]. The highly viscous
colanic acid [34] is secreted into the extracellular environ-
ment to protect cells from osmotic stress such as provoked
by cell envelope perturbations, including peptidoglycan
damage or dessication [35]. In addition, colanic acid isinvolved in the later stages of biofilm formation; name-
ly, the maturation and development of complex three-
dimensional biofilm structures [24]. The wca operon is
comprised of 19 genes that are involved in colanic acid
synthesis from the nucleoside diphosphate sugars: GDP-
L-fucose, UDP-d-glucose, UDP-d-galactose and UDP-
D-glucuronate [36]. Colicin M treatment induced the
expression of all 19 of the wca genes.
Exposure to colicin M also up-regulated the D-galactose
transporter galP, as well as galU, which encodes the
glucose-1-phosphate uridylyltransferase that is needed for
UDP-glucose, an intermediate involved in the synthesis of
colanic acid, trehalose, lipopolysaccharide and membrane-
derived oligosaccharides [37].
Furthermore, our studies revealed strong induction of
the yjbEFGH operon that is involved in the production
of another, as-yet-unidentified, exopolysaccharide [38].
Recent studies have shown that the yjbEFGH operon is
also induced by osmotic stress, and that the wca and
yjbEFGH operons are negatively regulated by the general
stress response sigma factor RpoS (σ38) [39]. Both the
wca and the yjbEFGH operons are induced by the
activated Rcs pathway to protect the bacterial cell from
osmolysis.
Colicin M induced additional osmotic and other stress
responses
By inhibiting peptidoglycan synthesis, colicin M weakens
membrane protection, provoking osmotic stress. Inter-
estingly, genes creD, cbrA, cbrB and cbrC of the CreB/
CreC regulon were strongly induced already 30 min after
exposure to colicin M. The Cre system was previously
found to be involved in the switch from aerobic to an-
aerobic conditions. CreC is the sensor that also senses
changes in the growth medium and/or metabolite pool
levels, while CreB is a transcriptional regulator [40]. The
two-component CreBC system positively controls tran-
scription of cbrA. Recently, the CbrA protein was shown
to protect against colicin M and osmotic shock, implying
a function of CbrA in outer membrane structure [41].
Thus, it was proposed that in the natural environment
with a limited supply of nutrients, CbrA protects sensi-
tive cells from colicin M synthesized by competitors.
Furthermore, CbrC, which we also found to be induced
by colicin M treatment, has been shown to protect
against colicin E2 and also seems to be involved in alter-
ation of outer membrane structure [41]. Our results
indicate that subinhibitory concentrations of colicin M
could induce protection against colicins. Thus, in the nat-
ural environment, both colicin synthesis and the CreBC
system are induced upon nutrient limitation [42,43]. Coli-
cin produced in microbial communities by colicinogenic
bacteria could in colicin sensitive community members
induce protective responses. Moreover, activation of the
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shown to play a major role in the ß-lactam resistance re-
sponse [44] indicating that, subinhibitory concentrations
of colicin M might elicit broader antimicrobial protection.
It can also be noted that more than 100 of the open
reading frames up-regulated by colicin M treatment
are classified as poorly characterized or with predicted
functions. Among these, many are predicted mem-
brane proteins and lipoproteins indicating that, to pro-
tect cells against peptidoglycan damage provoked by
colicin M, an adaptive response to strengthen/stabilize
the osmosensitive membrane is induced.
To resist the effects of colicin M treatment, other
genes involved in the response to hyperosmotic stress
were up-regulated; namely, osmB and osmC [45] as well
as two inhibitors of C-lysozyme, ivy and a mem-
brane bound and predicted lipoprotein mliC, were also
induced by the Rcs system. Antibiotic-mediated peptido-
glycan stress has also been shown to trigger expression
of both of these genes [27].
Colicin M also induced other stress response genes,
including ydeI, which is involved in hydrogen peroxide
stress [46], as well as the ibpA and ibpB heat shock
genes, which encode chaperones that can cooperate to
prevent irreversible aggregation of proteins [47].
Colicin M induces biofilm associated genes
In natural environments, bacteria often form biofilms,
microbial communities in which bacteria adhere to an
abiotic or biotic surface via surface charges as well as
production of pili, fimbriae and exopolysaccharides. Mi-
crobial cells in biofilms show distinct properties,
particularly resistance to antibiotics, disinfectants, shear
stress and the immune system [48]. Biofilm formation
proceeds in several tightly regulated steps: initial attach-
ment, three-dimensional development by microcolony
formation, biofilm maturation and the final step dispersal
or cellular detachment to colonize other surfaces. Initially,
flagella promote motility toward a surface; subsequently,
flagella are lost and adhesive organelles such as curli
fimbria enable attachment; and finally, colanic acid pro-
duction promotes maturation into the three dimensional
biofilm structure [49,50].
Colicin M treatment upregulated several genes involved
in biofilm production. Thus, in addition to up-regulation
of colanic acid, colicin M treatment up-regulated rprA,
which encodes a small regulatory RNA affecting target
mRNA translation. Expression of rprA has been shown to
be activated by the Rsc system. RprA has been shown to
repress csgD. This latter encodes the master transcrip-
tional regulator that activates curli fimbriae and cellulose
synthesis, both of which are involved in the initial stage of
biofilm formation [51]. It has been postulated that by
interfering with csgD mRNA translation, RprA mightprevent the undesired co-expression of curli/cellulose and
colanic acid [52]. In accordance, as we found upregulation
of the colanic acid operon genes we also determined
upregulation of the omrA and omrB genes, which encode
two redundant small/antisense RNAs that have recently
been shown to inhibit CsgD translation [53].
Colicin M exposure up-regulated another biofilm-
associated gene, bdm, which encodes the biofilm-dependent
modulation protein. Bdm expression is positively regulated
by RcsB in response to osmotic shock [25], and the Bdm
protein has been recently shown to enhance biofilm forma-
tion [54].
The exposure to colicin M also upregulated ydeH,
which codes for a diguanylate cyclase that can synthesize
the second messenger bis-(30-50) cyclic di-guanosine
monophosphate (c-di-GMP) [55-57]. ydeH is positively
regulated by CpxR, and has been shown to inhibit motil-
ity as well as to promote adhesin and biofilm formation.
In E. coli, c-di-GMP controls the synthesis of two
exopolysaccharides: cellulose and poly-GlcNaC (PGA), a
virulence factor of uropathogenic E. coli [58]. Our study
thus showed that colicin M induced an envelope stress
response which could provoke switching from a plank-
tonic to a sessile lifestyle. Nevertheless, in crystal violet
assays no induction of biofilm formation was observed
(data not shown).
Colicin M treatment downregulates flagellar biosynthesis
genes
Not unexpectedly, among the down-regulated genes,
there were in particular the genes involved in flagellar
motility and in glutamine biosynthetic processes. In E.
coli, flagellar expression and motility is controlled by the
FlhDC complex that comprises >60 genes. Flagellar syn-
thesis and function are processes that demand high
energy consumption, and therefore, expression of the
flagellar genes is tightly regulated [59]. In contrast to
exopolysaccharide production, expression of the flhDC
operon has been shown to be down-regulated by numer-
ous environmental signals, such as high temperature,
high osmolarity (concentrations of salts, in the presence
of carbohydrates or low-molecular alcohols) and ex-
treme pH [60,61].
Both the exopolysaccharide synthesis operons, wca
and yjbEFGH, and the flagellar flhDC operon genes are
controlled by the Rcs phosphorelay system. However,
while the activated Rcs phosphorelay system induces
exopolysaccharide synthesis, it down-regulates the flhDC
operon due to repression by the RcsB cofactor RcsA.
Validation of microarray results by real-time PCR
The gene expression results from the microarray ana-
lyses of total RNA isolated from cultures exposed to
colicin M for 60 min were verified using qPCR. For this
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M treatment and from different functional groups, were
selected: ydeI, pspC, opgB, rprA, cpxP, ycfJ, rcsA, yjbE,
wcaD, spy, wzxC, wza, glnG and wza. For this compari-
son, the fold-changes of mRNA abundance of selected
genes after 60 min colicin M exposure were plotted as
those determined by qPCR versus those seen in the
microarray analysis. The qPCR results confirmed differ-
ential gene expression observed by microarray analysis
of the selected genes (Figure 3).
Colicin M treatment does not promote significantly
increased exopolysaccharide production
As the microarray data showed that the colanic acid op-
eron genes were among the most strongly induced, a
functional assay was performed to address whether the
amount of colanic acid was changed accordingly. Pro-
duction of colanic acid was quantified following expos-
ure of E. coli to colicin M. Colanic acid was extracted
from bacterial cultures treated with subinhibitory
concentrations of colicin M for 60min, 90 min and 120
min, as well as from an untreated control. While at the
mRNA level there was significant induction of the wca
operon genes, only a slight, 1.3-fold, increase in the pro-
duction of colanic acid was seen at all sampling times.
As an additional control, colanic acid was quantified
from a culture overexpressing the wca operon encoded
by a multicopy plasmid, pATC400 [62]. A 6-fold increase
in colanic acid production was seen in comparison with
an isogenic strain that did not overexpress the wca op-
eron genes.
Treatment of E. coli with colicin M promotes the hy-
drolysis of the peptidoglycan lipid precursors, which results
in the arrest of the polymerization steps and exposes theFigure 3 Validation of the microarray results by qPCR.
Expression analysis of the 14 selected genes determined by
microarray (open bars) and validated by qPCR (solid bars). The fold-
changes for the microarray and qPCR were calculated as described
(Materials and Methods) and represent gene expression levels
following 60 min exposure to colicin M.bacterial cells to envelope stress, which activates the Rcs
and Cpx phosphorelay systems. Subsequently, cell motility
is down-regulated, with induction of the expression of the
exopolysaccharide wca and the yjbEFGH operon genes.
Colicin M promoted hydrolysis of lipid II which prevents
recycling of the lipid carrier for peptidoglycan synthesis
and also limits its availability for exopolysaccharide biosyn-
thesis, including colanic acid.
Following an initial growth stagnation (Figure 1 and also
see Additional file 1: Figure S1), regrowth of cultures
treated with these subinhibitory concentrations of colicin
M indicate an adaptive response to the stress through the
activation of the envelope and other stress responses.
While neither an increase in colanic acid or biofilm
production was detected, in the natural environment, acti-
vation of the various above-described stress responses
might allow rapid adaptation, including mature biofilm
formation, in the event of a sudden decrease/absence in
antimicrobial concentrations.
Genome-wide transcriptional analysis and other
antimicrobials
A number of studies have shown that traditional
antibiotics affect bacterial gene expression and physi-
ology [1,2,63,64]. Thus, some β-lactam antibiotics that
can also inhibit peptidoglycan synthesis have been
shown to induce the production of colanic acid in E.
coli, which indicates that these might exacerbate biofilm
formation [65]. Investigation of the E. coli transcription
profile in response to bactericidal concentrations of
ampicillin also showed induction of the colanic acid bio-
synthetic pathway, as well as rcsA, the transcriptional ac-
tivator of colanic acid synthesis and other stress
responses [66]. However, the authors did not detect in-
duction of the additional exopolysaccharide operon
yjbEFGH, distinct from colanic acid. In Staphylococcus
aureus, subinhibitory concentrations of β-lactams have
been shown to up-regulate some virulence genes [67].
Moreover, the aminoglycoside tobramycin has been
shown to induce biofilm formation in E. coli and in
Pseudomonas aeruginosa, due to alterations in the levels
of c-di-GMP [68]. Biofilm formation was also induced
following exposure of P. aeruginosa to subinhibitory
concentrations of tetracycline and norfloxacin [69].
Further to this, a number of studies have investigated
the effects of antibiotics on the expression of the SOS
regulon genes. Thus, the β-lactam antibiotic, ceftazidime,
which is an inhibitor of a protein involved in cell wall
biosynthesis, PBP3, has been shown to induce transcrip-
tion of the dinB gene, which encodes the error-prone
DNA polymerase Pol IV [70]. Subsequently, subinhibitory
concentrations of ampicillin, norfloxacin and kanamycin
were shown to induce mutagenesis due to antibiotic-
mediated increases in reactive oxygen species, which
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multidrug resistance [71]. An additional study showed that
a number of antibiotics can promote an increase in muta-
tion frequency; namely, ampicillin, ceftazidime, imipenem,
ciprofloxacin, trimethoprim, sulfamethoxazole and tetra-
cycline [72]. With the exception of imipenem, fosfomycin
and tetracycline, the antibiotics tested were shown to in-
duce recA expression, while inactivation of recA abolished
the mutagenic effects.
In the present study, subinhibitory concentrations of
colicin M did not induce the expression of dinB or recA.
To further confirm that colicin M does not induce the
SOS response, induction of the sulA gene following coli-
cin M treatment was investigated. SOS-regulated SulA
inhibits cell division by binding to FtsZ, which is
required for septum formation. For this purpose, expres-
sion of the chromosomal sulA-lacZ fusion was studied
in the ENZ1257 strain [73] without and with colicin M:
no induction was detected (data not shown).
While colicins have been assumed to have roles in
defense or invasion of an ecological niche, previous stud-
ies have shown that colicins are also involved in the pro-
motion of microbial diversity within E. coli populations in
the mammalian colon [9,74]. Furthermore, the nuclease
colicins, E9 and E3, have been shown to have the potential
to promote microbial genetic diversity via induction of the
SOS response or via increased transcription of laterally
acquired mobile elements, respectively [75].
Another study showed that colicins from one producer
can induce production in another producer, thus resulting
in colicin-mediated colicin induction [74]. Here, we show
that subinhibitory concentrations of colicin M induced an
envelope and other stress responses including the two
component CreBC system connected with increased re-
sistance to colicins M and E2. In natural environments,
subinhibitory concentrations of colicin M could thus affect
E. coli bacterial communities by promoting ecological
adaptation enabling noncolicinogenic cells to survive and
compete with colicin producers. The above-described phe-
nomena might also be relevant in the natural settings of
other bacterial species, as colicin M homologous proteins
have been identified recently in human and plant patho-
genic Pseudomonas species that have hydrolytic activity
against peptidoglycan precursors [76]. Further, activation
of the P. aeruginosa CreBC system has been shown to play
a major role in the ß-lactam resistance response [44].
Resistance of pathogens to traditional antibiotics
represents one of the greatest health care threats. The
present lack of novel antibiotics is also of great concern.
Colicin M has been recently shown to hydrolyse lipid II
intermediates of Gram-negative and Gram-positive
bacteria [12]. In addition, as the isolated colicin M cata-
lytic domain displays full enzymatic activity, protein en-
gineering can be used to allow binding and translocationin various Gram-negative and Gram-positive species
[77,78]. Furthermore, low concentrations and low protein-
to-bacteria ratios suffice for colicin M to kill E. coli.
Targeting of lipid II has been indicated as a potential anti-
bacterial strategy [79].
Conclusion
In conclusion, subinhibitory concentrations of colicin M
induced genes involved in adaptive responses to protect
the population against envelope and other stresses, in-
cluding the two component CreBC system associated
with increased resistance to some colicins. Our study of
the global transcriptional response to colicin M thus
provides novel insight into the ecology of colicin M
production in natural environments. While an adaptive
response was provoked by colicin M treatment there
was no induction of biofilm formation, SOS response
genes, or other genes involved in mutagenesis, adverse
effects shown to be promoted by a number of clinically
significant traditional antibiotics. Thus, our study also
corroborates the potential of colicin M as a promising
antimicrobial and shows the value of microarrays for in-
vestigation of novel antimicrobials.
Methods
Colicin M expression and isolation
Prior to isolation of colicin M, the cma colicin M struc-
tural and cmi immunity genes were PCR amplified from
the natural colicin M coding plasmid pCHAP1 using
the primers ColM1 50-TCACTCGAGCATGGAAACCT
TAACTGTTCATGCA-30 and ColM2 50-CCACGCGT
CCACTTCACAGTATGCTCACATTG-30. The ampli-
fied fragment was digested with the XhoI and MluI
restriction enzymes and cloned into the pET8c expres-
sion vector, also cut with the same two enzymes [80].
The isolated plasmid was designated pColM-imm Clon-
ing of cma into the pET8c vector introduced an N-
terminal histidine tag with expression under the control
of a T7 promotor. Colicin M and the immunity protein
were subsequently expressed in E. coli BL21 (DE3)pLysS
and colicin M was purified using nickel affinity chroma-
tography [80,81].
For large scale isolation an overnight culture of BL21
(DE3)pLysS, with plasmid pColM-imm was diluted 100
fold in 500 ml LB with ampicillin (120 μg/ml) and grown
at 37°C to an OD600 0.6-0.8, when chromosomal T7 poly-
merase production was induced by addition of 0.8 mM
IPTG and incubated for a further 4 h. Subsequently, cells
were harvested and resuspended in 50mM phosphate,
300mM NaCl buffer, pH 8, containing RNaseA (20 μg/
ml), DNAse (10 μg/ml), lysozyme (1mg/ml), 10mM
imidazole as well as protein inhibitors and incubated for
1 h at 4°C with shaking. The cells were then lysed with 3
min sonification, 40% amplitude and the supernatant
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histidine-tag enabled Ni-NTA affinity column purification
according to the user’s manual (Qiagen). Nonspecifically
bound proteins were washed off the column with 50mM
phosphate, 300mM NaCl, pH 8.0 buffer, containing 50
mM imidazole while colicin M was subsequently eluted
with the same buffer containing 300mM imidazole.
The colicin-M-containing fractions, as established by
10% SDS-PAGE, were then dialyzed against 5 mM phos-
phate buffer, pH 7.3, centrifuged at 17,000 × g at 4°C for
30 min, and stored at −80°C. Colicin M purity was veri-
fied by SDS-PAGE (see Additional file 4: Figure S3), and
(a concentration of 3.4 mg/ml) protein concentrations
were determined using bicinchoninic acid protein assay
kits (Pierce) and a Nanodrop ND 1000 spectrophotom-
eter (Thermo Scientific). Finally colicin M was stored
at −80°C.
Growth conditions
The agar dilution method (National Committee for
Clinical Laboratory Standards, 2000) was used to
determine the minimal inhibitory concentration
(MIC) of colicin M 50 ng/ml. For this purpose, an
overnight culture of E. coli MG1655 [13] was diluted
1:625 in LB broth and grown at 37°C with aeration
to an OD600 0.6 when the culture was divided into
several parts. One part served as a control while the
other parts were treated with various concentrations
of colicin M. The subinhibitory concentration (30 ng/ml)
provoked temporary growth stagnation while growth
decline was observed at higher concentrations, presum-
ably due to cell lysis (see Additional file 1: Figure S1
in Additional file 2: Figure S2).
To investigate the effects of colicin M on the whole
genome expression profile, an overnight culture of the E.
coli strain MG1655 (F-lambda-ilvG-rfb-50 rph-1) was
grown as described above. One part was treated with
colicin M (30 ng/ml), while the untreated part served as
the control. For gene expression analysis by microarray
and qPCR, total RNA was isolated from 2-ml samples
removed from each flask following 30min and 60 min
incubations at 37°C. The experiments were repeated at
least two times.
For quantification of colanic acid, the growth
conditions and the application of subinhibitory con-
centrations of colicin M were as described above.
Colanic acid was purified from 50ml cultures trea
ted with colicin M for 60 min, 90 min and 120 min at
37°C, with aeration. The experiment was repeated at
least two times.
RNA isolation
Total RNA was extracted using the RNAProtect Bacteria
Reagent (Qiagen) and RNeasy Mini kits (Qiagen),according to the manufacturer instructions. To remove re-
sidual DNA, on-column DNase digestion was performed
during the RNA purification using the RNase-Free DNase
Set (Qiagen). A Nanodrop ND 1000 spectrophotometer
(Thermo Scientific) was used to confirm total RNA
concentrations, while an Agilent 2100 Bioanalyser (Agilent
Technologies, CA, USA) was used to evaluate the RNA
quality. The isolated RNA was stored at −80°C until use.
Microarray procedures
Gene expression analysis was performed using Affy-
metrix GeneChipW E. coli Genome 2.0 arrays. Target pre-
paration, hybridization, washing, staining and scanning
were performed as recommended by the Affymetrix
GeneChipW Expression Analysis Technical Manual. The
experiment was repeated at least two times.
The acquisition of array images and the data quality as-
sessment were performed using an Affymetrix GeneChip
Command Console. The GeneChip data was processed
using several different R/Bioconductor packages. The
Affymetrix raw data were normalized using the RMA al-
gorithm from the XPS package. The data have been
deposited in the NCBI Gene Expression Omnibus data-
base (GEO, http://www.ncbi.nlm.nih.gov/geo) under GEO
series accession number GSE37026.
Annotation of the genes and the data representation was
managed using the ANNAFFY and AFFYCORETOOLS
packages. The normalized data, converted to log2 values,
were first limited to the ENTREZ-annotated probes from
strain K12 (10208 probes). The remaining data were tested
for differential expression, which was performed using the
LIMMA package for the 30-min treated versus the 30-min
untreated control and for the 60-min treated versus the
60-min untreated control bacterial culture. Differential ex-
pression was assessed using the 2-way factorial ANOVA
model constructed using LIMMA package. Differential ex-
pression was assessed using the false discovery rate multiple
test correction [82] and controlling type I error at α = 0.05.
Differential expression of genes is represented as log2
ratios between the treated and untreated samples averaged
over the two biological replicates. Important differentially
expressed genes with log2 (fold change) greater than 1 or
less than -1 denoting 2-fold up-regulated or down-
regulated genes over time were considered for interpret-
ation and are presented in Table 1. The expression of a
subset of selected genes was validated by quantitative real-
time PCR (qPCR) (see Additional file 5: Table S2).
Real-time PCR
qPCR was performed for 14 genes that showed significant
differential expression in the microarray analysis. Samples
of 1 μg total RNA were reverse transcribed to synthesize
cDNA using High Capacity cDNA Reverse Transcription
kits (Applied Biosystems), according to the manufacturer
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Green PCR Master Mix (Applied Biosystems) with an ABI
PRISM 7900 HT Sequence Detection System (Applied
Biosystems). The qPCR amplifications were performed as
follows: 50°C for 2min, 95°C for 10min, followed by 40 -
cycles of 95°C for 15 s and 60°C for 1 min, and a final
dissociation curve analysis step from 60°C to 95°C. Two
negative reverse transcription controls were used to show
no reverse transcription contamination. qPCR validation
was performed on four biological replicates.
Publicly available sequences of the transcripts from the
NetAffyx Analysis Centre (http://www.affymetrix.com/
analysis/netaffx/index.affx) were analyzed to select target
sequences, and the Primer3 software [83] and Primer
Express 3.0 software (Applied Biosystems) were used for
the design of the specific primers (Sigma). The primer
sequences are listed in Additional file 5: Table S2.
Raw data were acquired using the Sequence Detection
System software, version 2.3 (Applied Biosystems), and
gene expression levels were analyzed using the 2-δδCT
method [84], as the efficiency of the qPCR amplifications
for all of the genes tested was >90%. geNorm [85] (avail-
able from medgen.ugent.be/~jvdesomp/genorm) was used
to select the most stable genes, and out of the seven
housekeeping genes tested, lpp, aroE, gapA were used as
the reference genes, with their geometric mean used for
normalization. The results are presented as log2 ratios be-
tween gene expression of treated and untreated cultures
of four replicates, and they are presented as a comparison
with the microarray data (Figure 3).Colanic acid quantification
Colanic acid was extracted from cultures grown and
treated with colicin M as described above, and from un-
treated control cultures incubated under the same
conditions. Colanic acid extraction and quantification was
performed as described previously [86]. Briefly, for quanti-
fication, the amount of nondialyzable methylpentose ω-
deoxyhexose (L-fucose), a component of colanic acid, was
measured using a colorimetric reaction with authentic L-
fucose (Sigma) as standard, and with concentrations
ranging from 5 μg/ml to 100 μg/ml. Colanic acid levels
were calculated as μg of nondialyzable ω-deoxyhexose/
unit A600 nm/ml of culture.Biofilm production
The ability to form biofilms was investigated using crys-
tal violet assays, as described previously [87]. To assess
the induction of biofilm formation, 100 μl of overnight
cultures were added to microtiter plates without and
with colicin M, and incubated for 24 h at 37°C. The
experiments were performed in triplicate.ß-Galactosidase assay
For quantification, the growth conditions and applica-
tion of subinhibitory concentrations of colicin M are as
described above. The ß-galactosidase activity of the
sulA-lacZ gene fusion was measured as described previ-
ously [88].
Additional files
Additional file 1: Figure S1. Growth of E. coli MG1655 treated with
colicin M. The arrow denotes the time of addition of colicin M, at
inhibitory (100 ng/ml, 50 ng/ml) and subinhibitory concentrations (30 ng/
ml, 20 ng/ml, 10 ng/ml). Growth curves represent E. coli MG1655 cultures
treated with different colicin M concentrations.
Additional file 2: Figure S2. Effect of subinhibitory concentrations of
colicin M on E. coli MG1566 viable counts. Growth curves with viable
counts (CFU/ml as a function of time relative to antibiotic addition) are
shown for untreated and treated culture (30 ng/ml of colicin M).
Additional file 3: Table S1. Time course analysis of differentially
expressed genes after 30 and 60 min exposure to subinhibitory
concentrations of colicin M. p≤0.05, log2 FC≥1 and ≤−1, log2 FC≤1,
≥−1; p≥0.05, log2 FC≥1 and ≤−1, log2 FC≤1, ≥−1. Log2 FC values in bold
correspond to log2 FC≥1 and ≤−1 when p≤0.05 and in regular type to
log2 FC≤1, ≥−1 when p≤0.05. Log2 FC values in italics bold correspond
to log2 FC≥1 and ≤−1 when p≥0.05 and in italics regular type to log2
FC≤1, ≥−1 when p≥0.05.
Additional file 4: Figure S3. SDS-PAGE gel showing purity of isolated
colicin M. Left, Protein ladder Page Ruler (Fermentas); Right, colicin M –
29.5 kDa, colicin M (3.4 mg/ml).
Additional file 5: Table S2. Primer pairs used for qRT-PCR in the
present study.
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